Kerafast

Kerafast, based in Boston, offers easy access to a diverse range of unique laboratory-made research tools globally, including cell lines, antibodies, and small molecules. Since 2011, over 200 institutions have contributed reagents to its platform, bypassing traditional Material Transfer Agreements. Kerafast manages all logistics for selling and shipping, providing generous royalty payments to labs and streamlining the procurement process for scientists. The company's mission fosters collaboration and accelerates scientific progress by facilitating access to rare reagents. In 2018, Kerafast merged with Absolute Antibody, aligning their vision to make recombinant antibody technology universally accessible, further enhancing their collective impact on the scientific community.